Centre hospitalier Lyon Sud

Lyon 69495

2 studies enrolling now · 19 studies all time

What they study most

Acute Myeloid Leukemia, Adenoid Cystic Carcinoma, Adult Acute Myeloid Leukemia, Advanced or Metastatic NRAS-mutant Melanoma, Agglutinin Disease, Cold, B-cell Chronic Lymphocytic Leukemia, Breast Cancer, Colorectal Cancer, Colorectal Cancer Metastatic, Diffuse Large B-cell Lymphoma, Glomus Tumor, Malignant, Hematological Malignancies

Studies at this site

• A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis — Recruiting now
• Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT — Recruiting now
• A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma — Running, not enrolling
• First-in-Human Study of ICT01 in Patients With Advanced Cancer — Running, not enrolling
• IPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma — Completed
• A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) — Running, not enrolling
• Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC — Running, not enrolling
• p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246 — Completed
• A Biomarker-Directed Phase 2 Trial of Tamibarotene (SY-1425) in Participants With Acute Myeloid Leukemia or Myelodysplastic Syndrome — Completed
• HIP Fracture Accelerated Surgical TreaTment And Care tracK (HIP ATTACK) Trial — Completed
• Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies — Stopped early
• A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion (Cardinal Study) — Completed
• Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer — Completed
• A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy — Completed
• Study to Evaluate Tolerability of Iberdomide (CC-220) in Combination With Polatuzumab Vedotin Plus Rituximab or Tafasitamab or Rituximab Plus Chemotherapy in B-cell Lymphoma — Withdrawn before enrolling
• Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) — Completed
• Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients — Completed
• Phase IIIb Study of APD421 in Combination as PONV Prophylaxis — Completed
• Bioequivalence Study of Azacitidine for Injection in Myelodysplastic Syndrome (MDS) Patients — Completed